File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: The Asia-Pacific consensus on ulcerative colitis
  • Basic View
  • Metadata View
  • XML View
TitleThe Asia-Pacific consensus on ulcerative colitis
 
AuthorsOoi, CJ1
Fock, KM10
Makharia, GK9
Goh, KL6
Ling, KL1
Hilmi, I6
Lim, WC11
Kelvin, T1
Gibson, PR4
Gearry, RB7
Ouyang, Q12
Sollano, J2
Manatsathit, S13
Rerknimitr, R5
Wei, SC3
Leung, WK14
De Silva, HJ8
Leong, RWL
 
KeywordsChemicals And Cas Registry Numbers
 
Issue Date2010
 
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGH
 
CitationJournal Of Gastroenterology And Hepatology, 2010, v. 25 n. 3, p. 453-468 [How to Cite?]
DOI: http://dx.doi.org/10.1111/j.1440-1746.2010.06241.x
 
AbstractInflammatory bowel disease (IBD) is increasing in many parts of the Asia-Pacific region. There is a need to improve the awareness of IBD and develop diagnostic and management recommendations relevant to the region. This evidence-based consensus focuses on the definition, epidemiology and management of ulcerative colitis (UC) in Asia. A multi-disciplinary group developed the consensus statements, reviewed the relevant literature, and voted on them anonymously using the Delphi method. The finalized statements were reviewed to determine the level of consensus, evidence quality and strength of recommendation. Infectious colitis must be excluded prior to diagnosing UC. Typical histology and macroscopic extent of the disease seen in the West is found in the Asia-Pacific region. Ulcerative colitis is increasing in many parts of Asia with gender distribution and age of diagnosis similar to the West. Extra-intestinal manifestations including primary sclerosing cholangitis are rarer than in the West. Clinical stratification of disease severity guides management. In Japan, leukocytapheresis is a treatment option. Access to biologic agents remains limited due to high cost and concern over opportunistic infections. The high endemic rates of hepatitis B virus infection require stringent screening before initiating immune-suppressive agents. Vaccination and prophylactic therapies should be initiated on a case-by-case basis and in accordance with local practice. Colorectal cancer complicates chronic colitis. A recent increase in UC is reported in the Asia-Pacific region. These consensus statements aim to improve the recognition of UC and assist clinicians in its management with particular relevance to the region. © 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
 
ISSN0815-9319
2012 Impact Factor: 3.325
2012 SCImago Journal Rankings: 0.985
 
DOIhttp://dx.doi.org/10.1111/j.1440-1746.2010.06241.x
 
ISI Accession Number IDWOS:000274939900005
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorOoi, CJ
 
dc.contributor.authorFock, KM
 
dc.contributor.authorMakharia, GK
 
dc.contributor.authorGoh, KL
 
dc.contributor.authorLing, KL
 
dc.contributor.authorHilmi, I
 
dc.contributor.authorLim, WC
 
dc.contributor.authorKelvin, T
 
dc.contributor.authorGibson, PR
 
dc.contributor.authorGearry, RB
 
dc.contributor.authorOuyang, Q
 
dc.contributor.authorSollano, J
 
dc.contributor.authorManatsathit, S
 
dc.contributor.authorRerknimitr, R
 
dc.contributor.authorWei, SC
 
dc.contributor.authorLeung, WK
 
dc.contributor.authorDe Silva, HJ
 
dc.contributor.authorLeong, RWL
 
dc.date.accessioned2011-04-04T07:57:24Z
 
dc.date.available2011-04-04T07:57:24Z
 
dc.date.issued2010
 
dc.description.abstractInflammatory bowel disease (IBD) is increasing in many parts of the Asia-Pacific region. There is a need to improve the awareness of IBD and develop diagnostic and management recommendations relevant to the region. This evidence-based consensus focuses on the definition, epidemiology and management of ulcerative colitis (UC) in Asia. A multi-disciplinary group developed the consensus statements, reviewed the relevant literature, and voted on them anonymously using the Delphi method. The finalized statements were reviewed to determine the level of consensus, evidence quality and strength of recommendation. Infectious colitis must be excluded prior to diagnosing UC. Typical histology and macroscopic extent of the disease seen in the West is found in the Asia-Pacific region. Ulcerative colitis is increasing in many parts of Asia with gender distribution and age of diagnosis similar to the West. Extra-intestinal manifestations including primary sclerosing cholangitis are rarer than in the West. Clinical stratification of disease severity guides management. In Japan, leukocytapheresis is a treatment option. Access to biologic agents remains limited due to high cost and concern over opportunistic infections. The high endemic rates of hepatitis B virus infection require stringent screening before initiating immune-suppressive agents. Vaccination and prophylactic therapies should be initiated on a case-by-case basis and in accordance with local practice. Colorectal cancer complicates chronic colitis. A recent increase in UC is reported in the Asia-Pacific region. These consensus statements aim to improve the recognition of UC and assist clinicians in its management with particular relevance to the region. © 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
 
dc.description.naturelink_to_OA_fulltext
 
dc.identifier.citationJournal Of Gastroenterology And Hepatology, 2010, v. 25 n. 3, p. 453-468 [How to Cite?]
DOI: http://dx.doi.org/10.1111/j.1440-1746.2010.06241.x
 
dc.identifier.citeulike6841344
 
dc.identifier.doihttp://dx.doi.org/10.1111/j.1440-1746.2010.06241.x
 
dc.identifier.eissn1440-1746
 
dc.identifier.epage468
 
dc.identifier.hkuros203859
 
dc.identifier.isiWOS:000274939900005
 
dc.identifier.issn0815-9319
2012 Impact Factor: 3.325
2012 SCImago Journal Rankings: 0.985
 
dc.identifier.issue3
 
dc.identifier.pmid20370724
 
dc.identifier.scopuseid_2-s2.0-77649226304
 
dc.identifier.spage453
 
dc.identifier.urihttp://hdl.handle.net/10722/132848
 
dc.identifier.volume25
 
dc.languageeng
 
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGH
 
dc.publisher.placeAustralia
 
dc.relation.ispartofJournal of Gastroenterology and Hepatology
 
dc.relation.referencesReferences in Scopus
 
dc.subject.meshColitis, Ulcerative - complications - diagnosis - drug therapy - epidemiology - therapy
 
dc.subject.meshColorectal Neoplasms - etiology
 
dc.subject.meshCongresses as Topic
 
dc.subject.meshHumans
 
dc.subject.meshImmunosuppressive Agents - therapeutic use
 
dc.subject.meshLeukapheresis - methods
 
dc.subject.meshPractice Guidelines as Topic
 
dc.subject.meshPrevalence
 
dc.subject.meshSeverity of Illness Index
 
dc.subject.meshSingapore - epidemiology
 
dc.subjectChemicals And Cas Registry Numbers
 
dc.titleThe Asia-Pacific consensus on ulcerative colitis
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Ooi, CJ</contributor.author>
<contributor.author>Fock, KM</contributor.author>
<contributor.author>Makharia, GK</contributor.author>
<contributor.author>Goh, KL</contributor.author>
<contributor.author>Ling, KL</contributor.author>
<contributor.author>Hilmi, I</contributor.author>
<contributor.author>Lim, WC</contributor.author>
<contributor.author>Kelvin, T</contributor.author>
<contributor.author>Gibson, PR</contributor.author>
<contributor.author>Gearry, RB</contributor.author>
<contributor.author>Ouyang, Q</contributor.author>
<contributor.author>Sollano, J</contributor.author>
<contributor.author>Manatsathit, S</contributor.author>
<contributor.author>Rerknimitr, R</contributor.author>
<contributor.author>Wei, SC</contributor.author>
<contributor.author>Leung, WK</contributor.author>
<contributor.author>De Silva, HJ</contributor.author>
<contributor.author>Leong, RWL</contributor.author>
<date.accessioned>2011-04-04T07:57:24Z</date.accessioned>
<date.available>2011-04-04T07:57:24Z</date.available>
<date.issued>2010</date.issued>
<identifier.citation>Journal Of Gastroenterology And Hepatology, 2010, v. 25 n. 3, p. 453-468</identifier.citation>
<identifier.issn>0815-9319</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/132848</identifier.uri>
<description.abstract>Inflammatory bowel disease (IBD) is increasing in many parts of the Asia-Pacific region. There is a need to improve the awareness of IBD and develop diagnostic and management recommendations relevant to the region. This evidence-based consensus focuses on the definition, epidemiology and management of ulcerative colitis (UC) in Asia. A multi-disciplinary group developed the consensus statements, reviewed the relevant literature, and voted on them anonymously using the Delphi method. The finalized statements were reviewed to determine the level of consensus, evidence quality and strength of recommendation. Infectious colitis must be excluded prior to diagnosing UC. Typical histology and macroscopic extent of the disease seen in the West is found in the Asia-Pacific region. Ulcerative colitis is increasing in many parts of Asia with gender distribution and age of diagnosis similar to the West. Extra-intestinal manifestations including primary sclerosing cholangitis are rarer than in the West. Clinical stratification of disease severity guides management. In Japan, leukocytapheresis is a treatment option. Access to biologic agents remains limited due to high cost and concern over opportunistic infections. The high endemic rates of hepatitis B virus infection require stringent screening before initiating immune-suppressive agents. Vaccination and prophylactic therapies should be initiated on a case-by-case basis and in accordance with local practice. Colorectal cancer complicates chronic colitis. A recent increase in UC is reported in the Asia-Pacific region. These consensus statements aim to improve the recognition of UC and assist clinicians in its management with particular relevance to the region. &#169; 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.</description.abstract>
<language>eng</language>
<publisher>Wiley-Blackwell Publishing Asia. The Journal&apos;s web site is located at http://www.blackwellpublishing.com/journals/JGH</publisher>
<relation.ispartof>Journal of Gastroenterology and Hepatology</relation.ispartof>
<subject>Chemicals And Cas Registry Numbers</subject>
<subject.mesh>Colitis, Ulcerative - complications - diagnosis - drug therapy - epidemiology - therapy</subject.mesh>
<subject.mesh>Colorectal Neoplasms - etiology</subject.mesh>
<subject.mesh>Congresses as Topic</subject.mesh>
<subject.mesh>Humans</subject.mesh>
<subject.mesh>Immunosuppressive Agents - therapeutic use</subject.mesh>
<subject.mesh>Leukapheresis - methods</subject.mesh>
<subject.mesh>Practice Guidelines as Topic</subject.mesh>
<subject.mesh>Prevalence</subject.mesh>
<subject.mesh>Severity of Illness Index</subject.mesh>
<subject.mesh>Singapore - epidemiology</subject.mesh>
<title>The Asia-Pacific consensus on ulcerative colitis</title>
<type>Article</type>
<description.nature>link_to_OA_fulltext</description.nature>
<identifier.doi>10.1111/j.1440-1746.2010.06241.x</identifier.doi>
<identifier.pmid>20370724</identifier.pmid>
<identifier.scopus>eid_2-s2.0-77649226304</identifier.scopus>
<identifier.hkuros>203859</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-77649226304&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>25</identifier.volume>
<identifier.issue>3</identifier.issue>
<identifier.spage>453</identifier.spage>
<identifier.epage>468</identifier.epage>
<identifier.eissn>1440-1746</identifier.eissn>
<identifier.isi>WOS:000274939900005</identifier.isi>
<publisher.place>Australia</publisher.place>
<identifier.citeulike>6841344</identifier.citeulike>
<bitstream.url>http://hub.hku.hk/bitstream/10722/132848/1/re01.htm</bitstream.url>
</item>
Author Affiliations
  1. Singapore General Hospital
  2. University of Santo Tomas, Manila
  3. National Taiwan University
  4. Monash University
  5. Chulalongkorn University
  6. University of Malaya
  7. University of Otago
  8. University of Kelaniya
  9. All India Institute of Medical Sciences
  10. Changi General Hospital
  11. Tan Tock Seng Hospital
  12. Sichuan University
  13. Mahidol University
  14. Chinese University of Hong Kong
  15. University of New South Wales